Navigation Links
PolyOne Corporation Announces an Exclusive License Agreement with Battelle for Bio-Plasticizer Technology
Date:8/5/2008

AVON LAKE, Ohio, Aug. 5 /PRNewswire-FirstCall/ -- PolyOne Corporation (NYSE: POL), a premier provider of specialized polymer materials, services and solutions, announced today that it has entered into an exclusive license arrangement for a series of bio-based plasticizer technology patents owned by Battelle.

The global market for plasticizers is approximately $11 billion annually, with 90% of all production consumed in vinyl-based formulations. Specialty plasticizers currently account for about 20% of the market. PolyOne will seek to develop differentiated specialty plasticizer and vinyl compound offerings based in part on the technologies covered by these patents.

"The world is looking for bio-based alternatives to materials traditionally derived from petroleum-based feedstock. The Battelle plasticizer technology, which was developed with early stage funding from Ohio Soybean Council as part of their strategic thrust to create new industrial markets for soybeans, shows great promise as a path to commercially viable renewable plasticizers," said PolyOne's Rob Rosenau, senior vice president and general manager, Geon Performance Polymers.

PolyOne is a global leader in compounding and formulation and is committed to expanding its position in specialized technologies that enhance the overall sustainability of its customers and the global community. PolyOne has specialty plasticizer manufacturing operations in Orangeville, Ontario and St. Remi, Quebec, Canada.

About PolyOne Corporation

PolyOne Corporation, with annual revenues of more than $2.7 billion, is a premier provider of specialized polymer materials, services and solutions. Headquartered outside of Cleveland, Ohio USA, PolyOne has operations around the globe. For additional information on PolyOne, visit our new Web site at http://www.polyone.com

About Battelle

Battelle is the world's largest non-profit independent research and development organization, providing innovative solutions to the world's most pressing needs through its four global businesses: Laboratory Management, National Security, Energy Technology, and Health and Life Sciences. It advances scientific discovery and application by conducting $4 billion in global R&D annually through contract research, laboratory management and technology commercialization. Headquartered in Columbus, Ohio, Battelle oversees 20,400 employees in more than 120 locations worldwide, including seven national laboratories which Battelle manages or co-manages for the U.S. Department of Energy and the U.S. Department of Homeland Security. Battelle also is one of the nation's leading charitable trusts focusing on societal and economic impact and actively supporting and promoting science and math education.


'/>"/>
SOURCE PolyOne Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. United BioSource Corporation and CogState Ltd. Form Strategic Partnership to Support Cognitive Assessment in Clinical Research
2. Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2008
3. MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 11, 2008
4. MaxWell Biocorporation, LLC, and International Medical Information Technologies, Inc., Announce Partnership
5. Alsius Corporation to Host Second Quarter 2008 Financial Results Conference Call on August 7
6. The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future
7. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
8. Roche and Response Biomedical Corporation Aim to Reduce Vein-to-Brain Time with New Point-of-Care Cardiac Tests
9. CorVel Corporation Announces Earnings Release Webcast
10. Genzyme Corporation and PTC Therapeutics Announce Collaboration on Small Molecule for Genetic Diseases
11. Webcast Alert: Neogen Corporation Announces Year-End Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 A person commits a ... crime scene to track the criminal down. An ... Food and Drug Administration (FDA) uses DNA evidence to track ... Sound far-fetched? It,s not. The FDA has increasingly ... support investigations of foodborne illnesses. Put as simply as possible, ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... ... 2016 , ... Supplyframe, the Industry Network for electronics hardware ... . Located in Pasadena, Calif., the Design Lab’s mission is to bring together ... built and brought to market. , The Design Lab is Supplyframe’s physical representation ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
Breaking Biology Technology:
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
Breaking Biology News(10 mins):